絞り込み

16514

広告

Does the Novel Potassium-Competitive Acid Blocker Vonoprazan Cause More Hypergastrinemia than Conventional Proton Pump Inhibitors? A Multicenter Prospective Cross-Sectional Study.

著者 Kojima Y , Takeuchi T , Sanomura M , Higashino K , Kojima K , Fukumoto K , Takata K , Sakamoto H , Sakaguchi M , Tominaga K , Higuchi K
Digestion.2018 Feb 01 ; 97(1):70-75.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (236view , 0users)

Full Text Sources

The long-term administration of proton pump inhibitors (PPIs) is useful for preventing recurrent reflux esophagitis. On the other hand, several adverse reactions, such as an increase in the blood gastrin level, have been reported. The aim of the present study was to examine the increase in the blood gastrin level due to the long-term administration of conventional PPIs compared with vonoprazan.
PMID: 29393198 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード